SUNITINIB ZENTIVA

Capsule, hard, 25mg
RxActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength25mg
PackagingUkupno 30 kapsula tvrdih u bočici plastičnoj u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holderZENTIVA PHARMA DOO - DIO STRANOG DRUŠTVA PODGORICA
Authorization dateJuly 17, 2023

Analogs in Montenegro

20

Other medicines with the same active substance

Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026